Uncategorized

Physician Dispensing Overview II

Distributors that help clinics dispense pharmaceuticals normally offer a dispensing logbook and/or an electronic tracking and labeling system.  These systems enable the clinic to keep track of medications dispensed to their patients.  Medication tracking software can be simple or complex depending on your vendor.  We encourage our clinics to keep their dispensing system as simple as possible.

Practitioners that dispense to their patients typically offer a combination of pills, lotions, ointments and solutions.  Many of our customers focus on treating acute conditions so we see many orders for antibiotics, analgesics, cough & cold products as well as corticosteroidsVaccines are also offered as a complement to the dispensing process.  In the case of Northwind Pharmaceuticals, we will also provide medical supplies to our clinics. 

Point-of-care dispensing is not a path to riches.  There are companies that promote practitioner dispensing as a means to generate significant dollars but the simple truth is that it can provide a decent supplemental revenue stream to a healthy clinic.  If dispensing revenues are higher than those from medical treatments, something is very wrong!  A single physician/nurse practitioner can reasonably generate enough to cover one or two office staff members.

Schedule a free claims analysis now.

Let’s Talk now

Leader in AI-driven health benefits navigation Healthee partners with Northwind

Katherine Lurk | Mar 28th, 2025
A game-changer for employers looking to cut costs and gain control With healthcare costs continuing to rise, employers are seeking new ways to rein in spending without sacrificing the quality of benefits. This partnership enables Healthee clients to optimize prescription drug management, reducing costs through preferable generic drug pricing, high-touch chronic care programs, and more. … more »

continue reading

Healthcare Storm 2025: What Will It Be?

Phillip Berry | Jan 1st, 2025
When it comes to American healthcare, we’ve become really good at highlighting its failings. Watching the flurry of lamentations, frustrations, denigrations, and prognostications, over the last few weeks, would lead any rational person to believe that nothing is working in our healthcare system. And, not only is it “not working,” many people conclude that it … more »

continue reading

New Drugs to Market – October Update

Phillip Berry | Oct 25th, 2024
The Food and Drug Administration (FDA) approved three novel drug therapies in October. One of those therapies,  Hympavzi (marstacimab-hncq), is a medication indicated for the treatment of patients with Hemophilia A and Hemophilia B. Hympavzi utilizes a new pathway to help reduce the risk of bleeding episodes in patients with Hemophilia, a disease that impacts … more »

continue reading